393 related articles for article (PubMed ID: 25411345)
1. Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.
Romero I; Garrido F; Garcia-Lora AM
Cancer Res; 2014 Dec; 74(23):6750-7. PubMed ID: 25411345
[TBL] [Abstract][Full Text] [Related]
2. T lymphocytes restrain spontaneous metastases in permanent dormancy.
Romero I; Garrido C; Algarra I; Collado A; Garrido F; Garcia-Lora AM
Cancer Res; 2014 Apr; 74(7):1958-68. PubMed ID: 24531750
[TBL] [Abstract][Full Text] [Related]
3. Tumor dormancy and immunoescape.
Quesnel B
APMIS; 2008; 116(7-8):685-94. PubMed ID: 18834412
[TBL] [Abstract][Full Text] [Related]
4. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis.
Zhang P; Zhai Y; Cai Y; Zhao Y; Li Y
Adv Mater; 2019 Dec; 31(49):e1904156. PubMed ID: 31566275
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor immunity and cellular cancer therapies].
Catros-Quemener V; Bouet F; Genetet N
Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
[TBL] [Abstract][Full Text] [Related]
7. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
Arancia G; Malorni W; Donelli G
Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
[TBL] [Abstract][Full Text] [Related]
8. Tumour MHC class I downregulation and immunotherapy (Review).
Bubeník J
Oncol Rep; 2003; 10(6):2005-8. PubMed ID: 14534734
[TBL] [Abstract][Full Text] [Related]
9. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
Sharland A; Lee JH; Saidman S; Waneck GL
Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
[TBL] [Abstract][Full Text] [Related]
10. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
[TBL] [Abstract][Full Text] [Related]
11. Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state.
Farrar JD; Katz KH; Windsor J; Thrush G; Scheuermann RH; Uhr JW; Street NE
J Immunol; 1999 Mar; 162(5):2842-9. PubMed ID: 10072532
[TBL] [Abstract][Full Text] [Related]
12. Tumour dormancy: initiation, maintenance and termination in animals and humans.
Stewart TH; Hollinshead AC; Raman S
Can J Surg; 1991 Aug; 34(4):321-5. PubMed ID: 1868387
[TBL] [Abstract][Full Text] [Related]
13. Cancer immune escape: MHC expression in primary tumours versus metastases.
Garrido F; Aptsiauri N
Immunology; 2019 Dec; 158(4):255-266. PubMed ID: 31509607
[TBL] [Abstract][Full Text] [Related]
14. Bench to bedside: NK cells and control of metastasis.
Krasnova Y; Putz EM; Smyth MJ; Souza-Fonseca-Guimaraes F
Clin Immunol; 2017 Apr; 177():50-59. PubMed ID: 26476139
[TBL] [Abstract][Full Text] [Related]
15. Tumor dormancy: long-term survival in a hostile environment.
Quesnel B
Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
[TBL] [Abstract][Full Text] [Related]
16. The role of microRNAs in the control of innate immune response in cancer.
Jasinski-Bergner S; Mandelboim O; Seliger B
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217579
[TBL] [Abstract][Full Text] [Related]
17. The inherent premise of immunotherapy for cancer dormancy.
Manjili MH
Cancer Res; 2014 Dec; 74(23):6745-9. PubMed ID: 25411346
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells.
Sabel MS; Arora A; Su G; Mathiowitz E; Reineke JJ; Chang AE
Surgery; 2007 Nov; 142(5):749-60. PubMed ID: 17981196
[TBL] [Abstract][Full Text] [Related]
19. Control of Metastasis by NK Cells.
López-Soto A; Gonzalez S; Smyth MJ; Galluzzi L
Cancer Cell; 2017 Aug; 32(2):135-154. PubMed ID: 28810142
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of cellular immune response by Ipomoea obscura and Ipobscurine alkaloid attenuates tumor growth in mice.
Hamsa TP; Kuttan G
Can J Physiol Pharmacol; 2011 Apr; 89(4):259-68. PubMed ID: 21539469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]